Create a Report

Please provide report title
Please provide location
Please provide details

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by

Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Covid-19 OSHA Complaint, Naza Beauty, 985 Valencia Street, SAN FRANCISCO, CA, 94110, USA

2 years ago

Covid-19 OSHA Complaint, Naza Beauty, 985 Valencia Street, SAN FRANCISCO, CA, 94110, USA

985 Valencia Street, San Francisco, 94110 California, United States

On December 12/22/21 an employee tested positive for covid-19 while on site. Once tested positive the employee was sent home, however the rest of the staff were expected to continue with salon services and handle clients. This is the third time an employee has had covid and every time management and the owner does not do proper safety measures. Employee are expected to work the following day although some have stated they don't feel safe. T8 CCR 3205(c)(3)(B): (3) Investigating and responding to COVID-19 cases in the workplace. (B) The employer shall take the following actions when there has been a COVID-19 case at the place of employment: 1. Determine the day and time the COVID-19 case was last present and, to the extent possible, the date of the positive COVID-19 test(s) and/or diagnosis, and the date the COVID-19 case first had one or more COVID-19 symptoms, if any were experienced. 2. Determine who may have had a close contact. This requires an evaluation of the activities of the COVID-19 case and all locations at the workplace which may have been visited by the COVID-19 case during the high-risk exposure period. NOTE: See subsection (c)(9) for exclusion requirements for employees after a close contact. 3. Within one business day of the time the employer knew or should have known of a COVID-19 case, the employer shall give written notice, in a form readily understandable by employees, that people at the worksite may have been exposed to COVID-19. The notice shall be written in a way that does not reveal any personal identifying information of the COVID-19 case. Written notice may include, but is not limited to, personal service, email, or text message if it can reasonably be anticipated to be received by the employee within one business day of sending. The notice shall include the disinfection plan required by Labor Code section 6409.6(a)(4). The notice must be sent to the following: 1. Determine the day and time the COVID-19 case was last present and, to the extent possible, the date of the positive COVID-19 test(s) and/or diagnosis, and the date the COVID-19 case first had one or more COVID-19 symptoms, if any were experienced. 2. Determine who may have had a close contact. This requires an evaluation of the activities of the COVID-19 case and all locations at the workplace which may have been visited by the COVID-19 case during the high-risk exposure period. NOTE: See subsection (c)(9) for exclusion requirements for employees after a close contact. 3. Within one business day of the time the employer knew or should have known of a COVID-19 case, the employer shall give written notice, in a form readily understandable by employees, that people at the worksite may have been exposed to COVID-19. The notice shall be written in a way that does not reveal any personal identifying information of the COVID-19 case. Written notice may include, but is not limited to, personal service, email, or text message if it can reasonably be anticipated to be received by the employee within one business day of sending. The notice shall include the disinfection plan required by Labor Code section 6409.6(a)(4). The notice must be sent to the following: a. All employees at the worksite during the high-risk exposure period. If the employer should reasonably know that an employee has not received the notice, or has limited literacy in the language used in the notice, the employer shall provide verbal notice, as soon as practicable, in a language understandable by the employee. b. Independent contractors and other employers at the worksite during the high-risk exposure period. 4. Within one business day of the time the employer knew or should have known of the COVID-19 case, the employer shall provide the notice required by Labor Code section 6409.6(a)(2) and (c) to the authorized representative of any employee at the worksite during the high-risk exposure period. 5. Make COVID-19 testing available at no cost, during paid t

Alleged Hazards: 3, Employees Exposed: 5
Source: Osha.gov | Receipt Date: 2021-12-22

#coronaviruscovid19 #osha #985valenciastreet #sanfrancisco #california #us

Recent Interesting Reports

F
I have received a package that was not ordered. The package came in one package USPS WHITE PLASTIC ENVELOPE MAILER. The package had a card inside from a website: support @oversprise. com. The inside content was 2 lucky boxes: one containing a smart watch smart Band 7. … See More
The other one contained knockoff apple earbuds. What am I to do with them now. I didn't order and want to return.
See Less

#unorderedpackage #delivery #uspostalservice #florence #southcarolina #us

C

They took from me Credit Card, Emporia, VA 23847, USA

2 weeks ago reported by user-cktw7545

This order this air pump a change for my car. For Mqc and never received it. They took my money from my account

They sent me something that I didn’t order
192-01 Northern Blvd flushing NY 11358 sent me some. KETO -ACV and I never ordered this

#scam #onlineshopping #delivery #onlinescam #emporia #virginia #us

D
So I went to the mailbox. It was in my mailbox a ring addressed to me that I did not order.
Sorry I just saw it was health issue. From Yoshi deals and I see a lot of other people got things they did not order.

#unorderedpackage #gramoissaniteringscam #delivery #lancaster #california #us

C

Unordered Package, Groveland, MA, USA

2 days ago reported by user-cnkv6673

I received a bottle of detox daily detox slim fitfusion I did not order this I don't know how they got my address I better not be charged I just had to change my debit card because someone stole it so I'm sure that this has something … See More
to do with that how do I send it back I better not be getting charged
See Less

#unorderedpackage #groveland #massachusetts #us

STOP CLOPEZ CORP is voluntarily recalling one lot of Schwinnng capsules to the consumer level. FDA analysis has found the Schwinnng products to contain Nortadalafil. Nortadalafil is an active drug ingredient known for the treatment of male erectile dysfunction. The presence of Nortadalafil in Schwinnng capsules makes … See More
it an unapproved new drug for which the safety and efficacy have not been established and, therefore subject to recall. The product was distributed Worldwide via Amazon at www.amazon.com. To date, no adverse events have been reported.

The Schwinnng products contain Nortadalafil, which may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may cause a significant drop in blood pressure that may be life threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk.

This product is marketed as a dietary supplement for male sexual enhancement and is packaged and coded as follows:

SCHWINNNG Lot 2108 EXP 10/2024

STOP CLOPEZ CORP is notifying its customers by this press announcement of this recall release and is arranging for a return of all recalled products. Consumers that have a Schwinnng product that is being recalled should stop using and destroy / return if desired to STOP CLOPEZ CORP. Schwinnng products must include the blister pack foil (with any pills remaining) containing all lot codes and receipt of proof of purchase, and your return address.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Link to FDA Advisory

If you are experiencing symptoms after eating this product it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist seek medical attention.

Company name: STOP CLOPEZ CORP
Brand name: Schwinnng
Product recalled: Herbal Dietary Supplement
Reason of the recall: Product is tainted with Nortadalafil
FDA Recall date: April 23, 2024

Source: www.fda.gov
See Less

#recall #drugs #us

Last 30 days